Genetically Engineered Gut Bacteria Offer New Hope for Kidney Stone Treatment
Researchers at Stanford have genetically modified gut bacteria to break down oxalate, a substance linked to kidney stones, showing promising results in rats and early human trials, though challenges like bacterial mutation remain to be addressed.